Read More Pharma Industry News Could MTX-001 emerge as a late-stage wound care contender after the latest FDA alignment? Could MTX-001 emerge as a late-stage wound care contender? Read why Merakris Therapeutics’ latest FDA alignment may reshape the commercial outlook. bySoujanya RaviApril 11, 2026